Health ❯ Healthcare ❯ Medical Research

Neurology

Alzheimer's Disease Dementia Parkinson's Disease Migraine Treatment Stroke Multiple Sclerosis Neurodegenerative Diseases ALS Treatment Cognitive Motor Dissociation Sturge-Weber Syndrome

Dual Blood Markers Sharpen Alzheimer’s Diagnosis by Cutting False Positives

A later-stage tau signal helps doctors tell symptomatic Alzheimer’s from early brain changes.

Stories older than 24h

PrimeC Shows Safety and Potential Benefit in ALS Phase 2b as FDA Authorizes Phase 3

Blood Test Using p‑Tau217 Predicts Dementia Risk in Women Up to 25 Years Before Symptoms

Early Alzheimer’s Markers Identified in Peripheral Retina in Mouse Study

Blood ‘Clock’ Predicts Alzheimer’s Symptom Onset Within 3–4 Years

Anti-Seizure Drug Levetiracetam Blocks Early Alzheimer’s Protein Production, Study Finds

Finger‑Prick Alzheimer’s Blood Test Moves Forward in International Trial With 883 Enrolled

Finger-Prick Blood Spot Test Detects Alzheimer’s Biomarkers With 86% Accuracy

Finger-Prick Dried Blood Test Flags Alzheimer’s Biomarkers in European Study

Largest Blood-Test Study Finds Alzheimer’s Changes Common in Older Adults

American Headache Society Elevates Nerve Blocks, IV Prochlorperazine to Must‑Offer ED Migraine Care

Novo Defends Semaglutide Alzheimer’s Strategy After Phase 3 Miss

Shingles Vaccine, Viagra and Riluzole Topped Exeter-Led List for Potential Alzheimer’s Repurposing

Mayo Clinic Model Estimates 10-Year and Lifetime Risk of Cognitive Decline

Alzheimer’s Social Memory Loss Linked to Perineuronal Net Breakdown in Mice

Fujirebio to Seek Year-End Approval for Japan’s First Alzheimer’s Blood Test

Argentine Team Maps Blood Metabolite Signature Linked to Epilepsy in Discovery-Stage Study

MS Trial Finds Metformin–Clemastine Combo Shows Early Myelin-Repair Signal

Ocrelizumab Outperforms Rivals on MS Relapse Control in Real-World Study

Nature Medicine: p‑tau217 Blood Test Accurately Flags Alzheimer’s on Automated Platform